Skip to content

Carsickness Therapy Based on Brain–Computer Interface Enhanced Mindfulness Meditation Training

Jiawei Zhu, Zhenfu Wen, Yonghao Cao, Qiyun Huang, Yuanqing Li

medRxiv Preprint Server April 1, 2026 preprint DOI: 10.64898/2026.04.01.26349963 via medRxiv

Summary

A wearable mindfulness meditation brain–computer interface (MM-BCI) system was tested in a 10-week randomized controlled trial involving 60 individuals susceptible to carsickness. Participants using the MM-BCI reported significantly reduced carsickness severity compared to those receiving sham feedback, both immediately after the intervention and at a one-month follow-up. Additionally, neural changes associated with mindfulness practice were linked to symptom improvement. This suggests that BCI-enhanced mindfulness meditation may be an effective non-drug treatment for carsickness.

Study at a glance

Design randomized controlled trial
Sample size 60
Population individuals susceptible to carsickness
Key finding The MM-BCI group showed significantly reduced carsickness severity at post-intervention and follow-up compared to the sham group.

Abstract

Carsickness impairs comfort and affects a large proportion of the population. However, interventions that provide a therapeutic solution to carsickness have yet to be established. Here we introduce a wearable mindfulness meditation brain–computer interface (MM-BCI) system as a closed-loop training therapy for carsickness. The system records electroencephalographic activity, decodes meditative state in real time and delivers audiovisual neurofeedback to scaffold meditation practice. In a 10-week randomized controlled trial, 60 individuals susceptible to carsickness were assigned to practice mindfulness meditation with either real-time MM-BCI neurofeedback or sham feedback, both during real-world car riding and at home. Critically, pre-intervention, post-intervention, and one-month follow-up assessments of carsickness severity were conducted during regular car riding without any task or feedback system. Relative to the sham group, the MM-BCI group showed significantly reduced carsickness severity at post-intervention and follow-up. At baseline, carsickness-susceptible participants exhibited a reduced aperiodic exponent in occipito-parietal cortex relative to non-susceptible controls, identifying a candidate neural signature of carsickness susceptibility. MM-BCI training increased this exponent toward non-susceptible levels, and the magnitude of this neural normalization was associated with the degree of symptom improvement. This study provides the first demonstration that BCI-enhanced mindfulness meditation can induce promising treatment effect on carsickness, offering a transformative non-pharmacological approach to enhance passenger well-being in everyday transit.

Comments

No comments yet.

Log in to comment